140 related articles for article (PubMed ID: 17322567)
1. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Nelson.
Nelson RM
Acad Emerg Med; 2007 Apr; 14(4):e43-4. PubMed ID: 17322567
[No Abstract] [Full Text] [Related]
2. Food and Drug Administration public hearing of the conduct of emergency clinical research: testimony of Dr. Dutton.
Dutton RP
Acad Emerg Med; 2007 Apr; 14(4):e33-6. PubMed ID: 17400992
[No Abstract] [Full Text] [Related]
3. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Schmidt.
Schmidt TA
Acad Emerg Med; 2007 Apr; 14(4):e59-62. PubMed ID: 17331913
[No Abstract] [Full Text] [Related]
4. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Weisfeldt.
Weisfeldt ML
Acad Emerg Med; 2007 Apr; 14(4):e69. PubMed ID: 17331914
[No Abstract] [Full Text] [Related]
5. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration "exception from informed consent requirements for emergency research": testimony of the American Heart Association.
Halperin H;
Acad Emerg Med; 2007 Apr; 14(4):e37-9. PubMed ID: 17400993
[No Abstract] [Full Text] [Related]
6. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Pediatric Emergency Care Applied Research Network.
Chamberlain JM; Singh T; Baren JM; Maio RF;
Acad Emerg Med; 2007 Apr; 14(4):e41-2. PubMed ID: 17322568
[No Abstract] [Full Text] [Related]
7. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Pepe--defending the rights of all individuals to have access to potential life-saving therapies and resuscitation studies.
Pepe PE
Acad Emerg Med; 2007 Apr; 14(4):e51-6. PubMed ID: 17341677
[No Abstract] [Full Text] [Related]
8. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American Stroke Association.
Saver JL;
Acad Emerg Med; 2007 Apr; 14(4):e57-8. PubMed ID: 17322569
[No Abstract] [Full Text] [Related]
9. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration's "Exception from informed consent requirements for emergency research": a special report from the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine.
Halperin H; Paradis N; Mosesso V; Nichol G; Sayre M; Ornato JP; Gerardi M; Nadkarni VM; Berg R; Becker L; Siegler M; Collins M; Cairns CB; Biros MH; Vanden Hoek T; Peberdy MA; ;
Circulation; 2007 Oct; 116(16):1855-63. PubMed ID: 17893277
[No Abstract] [Full Text] [Related]
10. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American College of Emergency Physicians.
Cairns CB;
Acad Emerg Med; 2007 Apr; 14(4):e31-2. PubMed ID: 17331911
[No Abstract] [Full Text] [Related]
11. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
Weiskopf RB;
Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
[No Abstract] [Full Text] [Related]
12. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the Society for Academic Emergency Medicine.
Biros MH;
Acad Emerg Med; 2007 Apr; 14(4):e27-9. PubMed ID: 17322570
[No Abstract] [Full Text] [Related]
13. Struggling with the rule: the exception from informed consent in resuscitation research.
Biros M
Acad Emerg Med; 2007 Apr; 14(4):344-5. PubMed ID: 17400997
[No Abstract] [Full Text] [Related]
14. Response to Food and Drug Administration draft guidance statement on research into the treatment of life-threatening emergency conditions using exception from informed consent: testimony of the Resuscitation Outcomes Consortium.
Ornato JP
Acad Emerg Med; 2007 Apr; 14(4):e45-9. PubMed ID: 17400994
[No Abstract] [Full Text] [Related]
15. Effect of the final rule on the conduct of emergency clinical research.
Gonzalez SK; Helling TS
J Trauma; 2008 Jun; 64(6):1665-72. PubMed ID: 18545136
[TBL] [Abstract][Full Text] [Related]
16. Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community.
Shah AN; Sugarman J
Ann Emerg Med; 2003 Jan; 41(1):72-8. PubMed ID: 12514685
[TBL] [Abstract][Full Text] [Related]
17. The research on community consultation: an annotated bibliography.
Baren JM; Biros MH
Acad Emerg Med; 2007 Apr; 14(4):346-52. PubMed ID: 17400998
[TBL] [Abstract][Full Text] [Related]
18. An ethical analysis of exception from informed consent regulations.
Morris MC
Acad Emerg Med; 2005 Nov; 12(11):1113-9. PubMed ID: 16264082
[TBL] [Abstract][Full Text] [Related]
19. A burn center paradigm to fulfill deferred consent public disclosure and community consultation requirements for emergency care research.
Blackford MG; Falletta L; Andrews DA; Reed MD
Burns; 2012 Sep; 38(6):807-12. PubMed ID: 22459155
[TBL] [Abstract][Full Text] [Related]
20. Waiver of informed consent for emergency research and community disclosures and consultations.
Raju TN
J Investig Med; 2004 Mar; 52(2):109-12. PubMed ID: 15068226
[No Abstract] [Full Text] [Related]
[Next] [New Search]